The test detects chlamydia, gonorrhea, and trichomonas from a single patient sample.
Diagnostic systems strength was driven by strong growth in molecular and installations in Western Europe .
Revenues from the company’s molecular diagnostics business grew 6 percent, driven by continued strength in sales of women's health products.
Genome sequences from Neisseria gonorrhoeae isolates from the UK provided insights into transmission and resistance patterns.
Under the agreement, Goffin will distribute SpeeDx's PlexPCR and ResistancePlus multiplex real-time PCR product lines in Benelux.
The firm increased its MDx revenues 7 percent from a year ago and beat the consensus Wall Street estimates on the top and bottom lines.
The revenue increase was driven by growth in Meridian's Diagnostics segment and particularly sales of its Illumigene product line.
The CE mark is for two assays covering chlamydia, gonorrhea, and trichomonas, and which run on the BD Max system.
Meridian received the CE mark for two new Illumigene molecular diagnostic tests for Chlamydia trachomatis and Neisseria gonorrhoeae.
According to the firm's CEO, the delay in launching the io system is due to a decision to automate parts of its platform, resulting in increased multiplexing.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.
In Nature this week: genetic history of HIV in the US, and more.
There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.
A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.